Patients with coronary artery disease who have received intra-coronary, drug-eluding stents (DES) may benefit from longer courses of clopidogrel than is currently standard.
Bivalirudin has been shown to provide equivalent outcomes, but less bleeding in patients undergoing elective percutaneous coronary interventions (PCI).
The amount of myocardial scar on MRI predicts the clinical response to cardiac resynchronization.
The same appearances in presentation of men and women with ACS can largely be explained by factors other than sex.
In the Framingham study non-HDL cholesterol is a stonger predictor of subsequent CHD than LDL cholesterol.
